An article in the most recent issue of the Food and Drug Law Institute’s FDLI Update talks about the important benefits — and risks — when a corporate defendant tells the prosecutor that “my lawyer said it was OK.”

The article (pdf) was written by John Fleder, a principal in the Washington, D.C., office of Hyman, Phelps & McNamara. Fleder writes that the government has become more aggressive in prosecuting corporate lawyers who become part of a fraudulent scheme.